Originally developed for type-2 diabetes, drugs such as semaglutide (Ozempic, Wegovy) from Novo Nordisk and tirzepatide (Mounjaro, Zepbound) from Eli Lilly and Company have become synonymous with modern pharmacologic weight management
We assess medical histories
The most common reasons: using a standard (non-effervescent, non-liposomal) capsule with poor gut absorption, inconsistent daily use, expecting visible results before the typical 8-12 week window, unrealistic expectations set by marketing claims, low supporting nutrients like Vitamin C, or continued sun exposure without adequate sunscreen, which counteracts skin brightening effects
IGF-1 LR3 is one of the most powerful growth agents in the performance enhancement world and for good reason
Clin Gastroenterol Hepatol 2024;22:1226-37.ArticlePubMed 13
Lets tackle some of the most common concerns we hear every day